Patent details

EP3065772 Title: COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER

Basic Information

Publication number:
EP3065772
PCT Application Number:
US2014064133
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP148596349
PCT Publication Number:
WO2015069770
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER
French Title of Invention:
COMBINAISONS D'INHIBITEURS DE POINT DE CONTRÔLE ET D'AGENTS THÉRAPEUTIQUES POUR TRAITER UN CANCER
German Title of Invention:
KOMBINATIONEN AUS CHECKPOINT-INHIBITOREN UND THERAPEUTIKA ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
05/11/2014
Grant date:
24/07/2024
EP Publication Date:
14/09/2016
PCT Publication Date:
14/05/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2024
EP B1 Publication Date:
24/07/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/11/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2024
 
 

Name:
Cognate Bioservices, Inc.
Address:
7513 Connelley Drive, Hanover, MD 21076, United States (US)

Name:
NorthWest Biotherapeutics, Inc.
Address:
4800 Montgomery Lane, Suite 800, Bethesda, MD 20814, United States (US)

Name:
REVIMMUNE, INC.
Address:
7513 Connelley Drive, Hanover MD 21076, United States (US)

Name:
The Regents of the University of California
Address:
1111 Franklin Street, 12th Floor, Oakland, CA 94607, United States (US)

Inventor

1

Name:
POWERS, Linda, F.
Address:
United States (US)

2

Name:
BOSCH, Marnix, Leo
Address:
United States (US)

3

Name:
GANJEI, James, Kelly
Address:
United States (US)

4

Name:
LIAU, Linda, M.
Address:
United States (US)

5

Name:
PRINS, Robert, M.
Address:
United States (US)

Priority

1

Priority Number:
201361900309 P
Priority Date:
05/11/2013
Priority Country:
United States (US)

2

Priority Number:
201361900355 P
Priority Date:
05/11/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/00; A61K 39/39; A61K 39/395; A61K 38/20; C07K 16/28; A61N 5/10; A61P 35/04; A61P 43/00; A61K 35/15; A61P 35/00; A61P 35/02; A61P 37/04;

Publication

European Patent Bulletin

1

Issue number:
202430
Publication date:
24/07/2024
Description:
Grant (B1)

2

Issue number:
202435
Publication date:
28/08/2024
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
02/06/2025
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages